Cantor Fitzgerald analyst Elemer Piros reiterates an Overweight rating on PolarityTE with $50 12-month price target after the company over the weekend presented 15 patient case studies of SkinTE during the podium presentation at the American Society of Plastic Surgeons' scientific meeting. The analyst feels "enthusiastic" about the changes PolarityTE has made over the last six months. Although its quarterly reports with revenue updates will be the key focus for investors in the near term, "positive trends" could come forward with the "newly formed, highly experienced" sales and marketing teams as well as the support of current management, Piros tells investors in a research note.